Fondazione Istituto Neurologico Mondino IRCCS

Pavia, Lombardy 27100

1 studies enrolling now · 4 studies all time

What they study most

LGI1 Autoimmune Encephalitis, Multiple Sclerosis, Primary Progressive, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), NMDAR Autoimmune Encephalitis, NMOSD, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) — Recruiting now
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis — Running, not enrolling